nodes	percent_of_prediction	percent_of_DWPC	metapath
Arsenic trioxide—ABCC2—Glyburide—gestational diabetes	0.372	0.657	CbGbCtD
Arsenic trioxide—ABCB1—Glyburide—gestational diabetes	0.121	0.214	CbGbCtD
Arsenic trioxide—CYP3A4—Glyburide—gestational diabetes	0.0726	0.128	CbGbCtD
Arsenic trioxide—CCND1—islet of Langerhans—gestational diabetes	0.00861	0.0451	CbGeAlD
Arsenic trioxide—CCND1—embryo—gestational diabetes	0.00832	0.0436	CbGeAlD
Arsenic trioxide—MAPK1—islet of Langerhans—gestational diabetes	0.00725	0.038	CbGeAlD
Arsenic trioxide—MAPK1—embryo—gestational diabetes	0.00701	0.0368	CbGeAlD
Arsenic trioxide—TXNRD1—islet of Langerhans—gestational diabetes	0.00675	0.0354	CbGeAlD
Arsenic trioxide—MAPK3—embryo—gestational diabetes	0.00621	0.0325	CbGeAlD
Arsenic trioxide—AKT1—islet of Langerhans—gestational diabetes	0.00605	0.0317	CbGeAlD
Arsenic trioxide—AKT1—embryo—gestational diabetes	0.00585	0.0307	CbGeAlD
Arsenic trioxide—CCND1—uterus—gestational diabetes	0.00561	0.0294	CbGeAlD
Arsenic trioxide—CCND1—adipose tissue—gestational diabetes	0.00549	0.0288	CbGeAlD
Arsenic trioxide—JUN—islet of Langerhans—gestational diabetes	0.00527	0.0276	CbGeAlD
Arsenic trioxide—JUN—embryo—gestational diabetes	0.00509	0.0267	CbGeAlD
Arsenic trioxide—IKBKB—embryo—gestational diabetes	0.00507	0.0266	CbGeAlD
Arsenic trioxide—MAPK1—uterus—gestational diabetes	0.00473	0.0248	CbGeAlD
Arsenic trioxide—MAPK1—adipose tissue—gestational diabetes	0.00463	0.0242	CbGeAlD
Arsenic trioxide—CCND1—vagina—gestational diabetes	0.00456	0.0239	CbGeAlD
Arsenic trioxide—TXNRD1—uterus—gestational diabetes	0.0044	0.0231	CbGeAlD
Arsenic trioxide—TXNRD1—adipose tissue—gestational diabetes	0.00431	0.0226	CbGeAlD
Arsenic trioxide—CCND1—head—gestational diabetes	0.00421	0.0221	CbGeAlD
Arsenic trioxide—MAPK3—uterus—gestational diabetes	0.00419	0.0219	CbGeAlD
Arsenic trioxide—MAPK3—adipose tissue—gestational diabetes	0.00409	0.0215	CbGeAlD
Arsenic trioxide—AKT1—uterus—gestational diabetes	0.00395	0.0207	CbGeAlD
Arsenic trioxide—AKT1—adipose tissue—gestational diabetes	0.00386	0.0202	CbGeAlD
Arsenic trioxide—MAPK1—vagina—gestational diabetes	0.00384	0.0202	CbGeAlD
Arsenic trioxide—TXNRD1—vagina—gestational diabetes	0.00358	0.0188	CbGeAlD
Arsenic trioxide—MAPK1—head—gestational diabetes	0.00355	0.0186	CbGeAlD
Arsenic trioxide—JUN—uterus—gestational diabetes	0.00344	0.018	CbGeAlD
Arsenic trioxide—IKBKB—uterus—gestational diabetes	0.00342	0.0179	CbGeAlD
Arsenic trioxide—MAPK3—vagina—gestational diabetes	0.0034	0.0178	CbGeAlD
Arsenic trioxide—JUN—adipose tissue—gestational diabetes	0.00336	0.0176	CbGeAlD
Arsenic trioxide—IKBKB—adipose tissue—gestational diabetes	0.00334	0.0175	CbGeAlD
Arsenic trioxide—TXNRD1—head—gestational diabetes	0.00331	0.0173	CbGeAlD
Arsenic trioxide—AKT1—vagina—gestational diabetes	0.00321	0.0168	CbGeAlD
Arsenic trioxide—MAPK3—head—gestational diabetes	0.00314	0.0165	CbGeAlD
Arsenic trioxide—AKT1—head—gestational diabetes	0.00296	0.0155	CbGeAlD
Arsenic trioxide—JUN—vagina—gestational diabetes	0.00279	0.0146	CbGeAlD
Arsenic trioxide—IKBKB—vagina—gestational diabetes	0.00278	0.0146	CbGeAlD
Arsenic trioxide—JUN—head—gestational diabetes	0.00258	0.0135	CbGeAlD
Arsenic trioxide—IKBKB—head—gestational diabetes	0.00257	0.0135	CbGeAlD
Arsenic trioxide—CYP1B1—uterus—gestational diabetes	0.00183	0.0096	CbGeAlD
Arsenic trioxide—CYP1B1—adipose tissue—gestational diabetes	0.00179	0.00939	CbGeAlD
Arsenic trioxide—CYP1B1—head—gestational diabetes	0.00138	0.00721	CbGeAlD
Arsenic trioxide—CYP1A1—uterus—gestational diabetes	0.00129	0.00679	CbGeAlD
Arsenic trioxide—CYP1A1—adipose tissue—gestational diabetes	0.00127	0.00664	CbGeAlD
Arsenic trioxide—CYP1A1—vagina—gestational diabetes	0.00105	0.00552	CbGeAlD
Arsenic trioxide—ABCB1—islet of Langerhans—gestational diabetes	0.00103	0.00541	CbGeAlD
Arsenic trioxide—ABCB1—embryo—gestational diabetes	0.000997	0.00523	CbGeAlD
Arsenic trioxide—CYP1A1—head—gestational diabetes	0.000972	0.0051	CbGeAlD
Arsenic trioxide—ABCB1—uterus—gestational diabetes	0.000672	0.00352	CbGeAlD
Arsenic trioxide—ABCB1—adipose tissue—gestational diabetes	0.000658	0.00345	CbGeAlD
Arsenic trioxide—ABCB1—vagina—gestational diabetes	0.000547	0.00287	CbGeAlD
Arsenic trioxide—ABCB1—head—gestational diabetes	0.000505	0.00265	CbGeAlD
Arsenic trioxide—AKT1—PI3K/AKT activation—FGF2—gestational diabetes	0.000452	0.00185	CbGpPWpGaD
Arsenic trioxide—MAPK1—Insulin receptor signalling cascade—FGF2—gestational diabetes	0.000449	0.00184	CbGpPWpGaD
Arsenic trioxide—MAPK1—IGF1R signaling cascade—FGF2—gestational diabetes	0.000449	0.00184	CbGpPWpGaD
Arsenic trioxide—AKT1—GAB1 signalosome—FGF2—gestational diabetes	0.000448	0.00184	CbGpPWpGaD
Arsenic trioxide—AKT1—Cardiac Hypertrophic Response—TNF—gestational diabetes	0.000447	0.00183	CbGpPWpGaD
Arsenic trioxide—MAPK1—Angiopoietin receptor Tie2-mediated signaling—TNF—gestational diabetes	0.000446	0.00183	CbGpPWpGaD
Arsenic trioxide—MAPK3—TGF-beta Receptor Signaling—TNF—gestational diabetes	0.00044	0.00181	CbGpPWpGaD
Arsenic trioxide—AKT1—Role of LAT2/NTAL/LAB on calcium mobilization—FGF2—gestational diabetes	0.000438	0.0018	CbGpPWpGaD
Arsenic trioxide—AKT1—Caspase Cascade in Apoptosis—TNF—gestational diabetes	0.000435	0.00178	CbGpPWpGaD
Arsenic trioxide—MAPK3—Cardiac Hypertrophic Response—TNF—gestational diabetes	0.000434	0.00178	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Aryl Hydrocarbon Receptor—TNF—gestational diabetes	0.000429	0.00176	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Aryl Hydrocarbon Receptor Pathway—TNF—gestational diabetes	0.000429	0.00176	CbGpPWpGaD
Arsenic trioxide—MAPK1—Apoptosis-related network due to altered Notch3 in ovarian cancer—TNF—gestational diabetes	0.000425	0.00174	CbGpPWpGaD
Arsenic trioxide—MAPK1—Cardiac Hypertrophic Response—TNF—gestational diabetes	0.000413	0.00169	CbGpPWpGaD
Arsenic trioxide—JUN—Downstream signaling in naïve CD8+ T cells—TNF—gestational diabetes	0.000402	0.00165	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Biological oxidations—GGCT—gestational diabetes	0.000402	0.00165	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Tryptophan metabolism—CYP19A1—gestational diabetes	0.000402	0.00165	CbGpPWpGaD
Arsenic trioxide—IKBKB—Cardiac Hypertrophic Response—TNF—gestational diabetes	0.000395	0.00162	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by Insulin receptor—FGF2—gestational diabetes	0.000392	0.00161	CbGpPWpGaD
Arsenic trioxide—TXNRD1—Metabolism—NAMPT—gestational diabetes	0.000381	0.00156	CbGpPWpGaD
Arsenic trioxide—TXNRD1—Metabolism—GCK—gestational diabetes	0.000379	0.00155	CbGpPWpGaD
Arsenic trioxide—MAPK3—Downstream signaling in naïve CD8+ T cells—TNF—gestational diabetes	0.000375	0.00154	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by Insulin receptor—FGF2—gestational diabetes	0.000373	0.00153	CbGpPWpGaD
Arsenic trioxide—CCND1—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	0.00036	0.00148	CbGpPWpGaD
Arsenic trioxide—JUN—Circadian rythm related genes—LEP—gestational diabetes	0.000357	0.00146	CbGpPWpGaD
Arsenic trioxide—MAPK1—Downstream signaling in naïve CD8+ T cells—TNF—gestational diabetes	0.000357	0.00146	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by SCF-KIT—FGF2—gestational diabetes	0.000346	0.00142	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—LEPR—gestational diabetes	0.000344	0.00141	CbGpPWpGaD
Arsenic trioxide—ABCB1—HIF-1-alpha transcription factor network—LEP—gestational diabetes	0.000342	0.0014	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by SCF-KIT—FGF2—gestational diabetes	0.000336	0.00138	CbGpPWpGaD
Arsenic trioxide—JUN—Innate Immune System—MBL2—gestational diabetes	0.000334	0.00137	CbGpPWpGaD
Arsenic trioxide—JUN—Apoptosis—TNF—gestational diabetes	0.000332	0.00136	CbGpPWpGaD
Arsenic trioxide—AKT1—Downstream signaling of activated FGFR—FGF2—gestational diabetes	0.000331	0.00136	CbGpPWpGaD
Arsenic trioxide—AKT1—Developmental Biology—GCK—gestational diabetes	0.000327	0.00134	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by ERBB4—FGF2—gestational diabetes	0.000326	0.00134	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.000325	0.00133	CbGpPWpGaD
Arsenic trioxide—MAPK3—Alzheimers Disease—TNF—gestational diabetes	0.000325	0.00133	CbGpPWpGaD
Arsenic trioxide—MAPK3—Downstream signaling of activated FGFR—FGF2—gestational diabetes	0.000321	0.00132	CbGpPWpGaD
Arsenic trioxide—MAPK3—Regulation of Actin Cytoskeleton—FGF2—gestational diabetes	0.000321	0.00132	CbGpPWpGaD
Arsenic trioxide—AKT1—Innate Immune System—MBL2—gestational diabetes	0.000321	0.00132	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.000321	0.00131	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by SCF-KIT—FGF2—gestational diabetes	0.000319	0.00131	CbGpPWpGaD
Arsenic trioxide—AKT1—MicroRNAs in cardiomyocyte hypertrophy—TNF—gestational diabetes	0.000319	0.00131	CbGpPWpGaD
Arsenic trioxide—AKT1—Apoptosis—TNF—gestational diabetes	0.000319	0.00131	CbGpPWpGaD
Arsenic trioxide—MAPK3—Developmental Biology—GCK—gestational diabetes	0.000317	0.0013	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by ERBB4—FGF2—gestational diabetes	0.000316	0.0013	CbGpPWpGaD
Arsenic trioxide—MAPK3—Innate Immune System—MBL2—gestational diabetes	0.000311	0.00128	CbGpPWpGaD
Arsenic trioxide—AKT1—Downstream signal transduction—FGF2—gestational diabetes	0.000311	0.00128	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by FGFR—FGF2—gestational diabetes	0.00031	0.00127	CbGpPWpGaD
Arsenic trioxide—MAPK3—MicroRNAs in cardiomyocyte hypertrophy—TNF—gestational diabetes	0.000309	0.00127	CbGpPWpGaD
Arsenic trioxide—MAPK1—Alzheimers Disease—TNF—gestational diabetes	0.000309	0.00127	CbGpPWpGaD
Arsenic trioxide—JUN—TNF alpha Signaling Pathway—TNF—gestational diabetes	0.000309	0.00126	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by ERBB2—FGF2—gestational diabetes	0.000308	0.00126	CbGpPWpGaD
Arsenic trioxide—AKT1—DAP12 signaling—FGF2—gestational diabetes	0.000307	0.00126	CbGpPWpGaD
Arsenic trioxide—MAPK1—Downstream signaling of activated FGFR—FGF2—gestational diabetes	0.000305	0.00125	CbGpPWpGaD
Arsenic trioxide—MAPK1—Regulation of Actin Cytoskeleton—FGF2—gestational diabetes	0.000305	0.00125	CbGpPWpGaD
Arsenic trioxide—AKT1—Downstream signaling events of B Cell Receptor (BCR)—FGF2—gestational diabetes	0.000302	0.00124	CbGpPWpGaD
Arsenic trioxide—MAPK3—Downstream signal transduction—FGF2—gestational diabetes	0.000302	0.00124	CbGpPWpGaD
Arsenic trioxide—MAPK1—Developmental Biology—GCK—gestational diabetes	0.000301	0.00124	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by ERBB4—FGF2—gestational diabetes	0.000301	0.00123	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by FGFR—FGF2—gestational diabetes	0.0003	0.00123	CbGpPWpGaD
Arsenic trioxide—JUN—Fc epsilon receptor (FCERI) signaling—FGF2—gestational diabetes	0.0003	0.00123	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by ERBB2—FGF2—gestational diabetes	0.000299	0.00122	CbGpPWpGaD
Arsenic trioxide—MAPK3—DAP12 signaling—FGF2—gestational diabetes	0.000297	0.00122	CbGpPWpGaD
Arsenic trioxide—AKT1—TNF alpha Signaling Pathway—TNF—gestational diabetes	0.000296	0.00122	CbGpPWpGaD
Arsenic trioxide—MAPK1—Innate Immune System—MBL2—gestational diabetes	0.000296	0.00121	CbGpPWpGaD
Arsenic trioxide—MAPK1—MicroRNAs in cardiomyocyte hypertrophy—TNF—gestational diabetes	0.000294	0.00121	CbGpPWpGaD
Arsenic trioxide—AKT1—Fc epsilon receptor (FCERI) signaling—FGF2—gestational diabetes	0.000288	0.00118	CbGpPWpGaD
Arsenic trioxide—AKT1—DAP12 interactions—FGF2—gestational diabetes	0.000288	0.00118	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by FGFR in disease—FGF2—gestational diabetes	0.000288	0.00118	CbGpPWpGaD
Arsenic trioxide—MAPK3—TNF alpha Signaling Pathway—TNF—gestational diabetes	0.000288	0.00118	CbGpPWpGaD
Arsenic trioxide—MAPK1—Downstream signal transduction—FGF2—gestational diabetes	0.000287	0.00118	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by EGFR—FGF2—gestational diabetes	0.000286	0.00117	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by FGFR—FGF2—gestational diabetes	0.000286	0.00117	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by ERBB2—FGF2—gestational diabetes	0.000284	0.00117	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Biological oxidations—CYP19A1—gestational diabetes	0.000284	0.00117	CbGpPWpGaD
Arsenic trioxide—JUN—Toll-like Receptor Signaling Pathway—TNF—gestational diabetes	0.000284	0.00116	CbGpPWpGaD
Arsenic trioxide—IKBKB—Innate Immune System—MBL2—gestational diabetes	0.000283	0.00116	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by EGFR in Cancer—FGF2—gestational diabetes	0.000283	0.00116	CbGpPWpGaD
Arsenic trioxide—MAPK1—DAP12 signaling—FGF2—gestational diabetes	0.000283	0.00116	CbGpPWpGaD
Arsenic trioxide—JUN—Integrated Pancreatic Cancer Pathway—FGF2—gestational diabetes	0.000282	0.00116	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by PDGF—FGF2—gestational diabetes	0.000282	0.00116	CbGpPWpGaD
Arsenic trioxide—IKBKB—Apoptosis—TNF—gestational diabetes	0.000281	0.00115	CbGpPWpGaD
Arsenic trioxide—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—TNF—gestational diabetes	0.000281	0.00115	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metapathway biotransformation—CYP19A1—gestational diabetes	0.00028	0.00115	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by FGFR in disease—FGF2—gestational diabetes	0.00028	0.00115	CbGpPWpGaD
Arsenic trioxide—MAPK3—Fc epsilon receptor (FCERI) signaling—FGF2—gestational diabetes	0.00028	0.00115	CbGpPWpGaD
Arsenic trioxide—MAPK3—DAP12 interactions—FGF2—gestational diabetes	0.00028	0.00115	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by EGFR—FGF2—gestational diabetes	0.000277	0.00114	CbGpPWpGaD
Arsenic trioxide—TXNRD1—Metabolism—CYP19A1—gestational diabetes	0.000277	0.00114	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by EGFR in Cancer—FGF2—gestational diabetes	0.000275	0.00113	CbGpPWpGaD
Arsenic trioxide—MAPK1—TNF alpha Signaling Pathway—TNF—gestational diabetes	0.000274	0.00112	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by PDGF—FGF2—gestational diabetes	0.000274	0.00112	CbGpPWpGaD
Arsenic trioxide—AKT1—Toll-like Receptor Signaling Pathway—TNF—gestational diabetes	0.000273	0.00112	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—GGCT—gestational diabetes	0.000273	0.00112	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—MTNR1B—gestational diabetes	0.000272	0.00112	CbGpPWpGaD
Arsenic trioxide—AKT1—Integrated Pancreatic Cancer Pathway—FGF2—gestational diabetes	0.000271	0.00111	CbGpPWpGaD
Arsenic trioxide—AKT1—Developmental Biology—ADIPOQ—gestational diabetes	0.000269	0.0011	CbGpPWpGaD
Arsenic trioxide—AKT1—B Cell Activation—FGF2—gestational diabetes	0.000267	0.00109	CbGpPWpGaD
Arsenic trioxide—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—FGF2—gestational diabetes	0.000267	0.00109	CbGpPWpGaD
Arsenic trioxide—MAPK1—DAP12 interactions—FGF2—gestational diabetes	0.000266	0.00109	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by FGFR in disease—FGF2—gestational diabetes	0.000266	0.00109	CbGpPWpGaD
Arsenic trioxide—MAPK1—Fc epsilon receptor (FCERI) signaling—FGF2—gestational diabetes	0.000266	0.00109	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—RBP4—gestational diabetes	0.000265	0.00109	CbGpPWpGaD
Arsenic trioxide—MAPK3—Toll-like Receptor Signaling Pathway—TNF—gestational diabetes	0.000265	0.00109	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Aryl Hydrocarbon Receptor—TNF—gestational diabetes	0.000264	0.00108	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—gestational diabetes	0.000264	0.00108	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by EGFR—FGF2—gestational diabetes	0.000264	0.00108	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.000263	0.00108	CbGpPWpGaD
Arsenic trioxide—MAPK3—Integrated Pancreatic Cancer Pathway—FGF2—gestational diabetes	0.000263	0.00108	CbGpPWpGaD
Arsenic trioxide—IKBKB—TNF alpha Signaling Pathway—TNF—gestational diabetes	0.000262	0.00107	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by EGFR in Cancer—FGF2—gestational diabetes	0.000261	0.00107	CbGpPWpGaD
Arsenic trioxide—MAPK3—Developmental Biology—ADIPOQ—gestational diabetes	0.000261	0.00107	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by PDGF—FGF2—gestational diabetes	0.00026	0.00107	CbGpPWpGaD
Arsenic trioxide—AKT1—NGF signalling via TRKA from the plasma membrane—FGF2—gestational diabetes	0.000255	0.00105	CbGpPWpGaD
Arsenic trioxide—IKBKB—Fc epsilon receptor (FCERI) signaling—FGF2—gestational diabetes	0.000255	0.00104	CbGpPWpGaD
Arsenic trioxide—MAPK1—Toll-like Receptor Signaling Pathway—TNF—gestational diabetes	0.000252	0.00103	CbGpPWpGaD
Arsenic trioxide—MAPK1—Integrated Pancreatic Cancer Pathway—FGF2—gestational diabetes	0.00025	0.00103	CbGpPWpGaD
Arsenic trioxide—MAPK1—Developmental Biology—ADIPOQ—gestational diabetes	0.000248	0.00102	CbGpPWpGaD
Arsenic trioxide—MAPK3—NGF signalling via TRKA from the plasma membrane—FGF2—gestational diabetes	0.000248	0.00102	CbGpPWpGaD
Arsenic trioxide—ABCC2—Transmembrane transport of small molecules—GCK—gestational diabetes	0.000241	0.000989	CbGpPWpGaD
Arsenic trioxide—IKBKB—Toll-like Receptor Signaling Pathway—TNF—gestational diabetes	0.000241	0.000988	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—GLS2—gestational diabetes	0.000239	0.000978	CbGpPWpGaD
Arsenic trioxide—MAPK1—NGF signalling via TRKA from the plasma membrane—FGF2—gestational diabetes	0.000236	0.000966	CbGpPWpGaD
Arsenic trioxide—IKBKB—B Cell Activation—FGF2—gestational diabetes	0.000236	0.000966	CbGpPWpGaD
Arsenic trioxide—MAPK3—Spinal Cord Injury—TNF—gestational diabetes	0.000236	0.000966	CbGpPWpGaD
Arsenic trioxide—AKT1—GPCR downstream signaling—MTNR1B—gestational diabetes	0.000233	0.000956	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—GGCT—gestational diabetes	0.000227	0.00093	CbGpPWpGaD
Arsenic trioxide—MAPK1—Spinal Cord Injury—TNF—gestational diabetes	0.000224	0.000919	CbGpPWpGaD
Arsenic trioxide—JUN—Regulation of toll-like receptor signaling pathway—TNF—gestational diabetes	0.000222	0.000909	CbGpPWpGaD
Arsenic trioxide—AKT1—Regulation of toll-like receptor signaling pathway—TNF—gestational diabetes	0.000213	0.000874	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by GPCR—MTNR1B—gestational diabetes	0.000212	0.000868	CbGpPWpGaD
Arsenic trioxide—MAPK3—Regulation of toll-like receptor signaling pathway—TNF—gestational diabetes	0.000207	0.000847	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—MTNR1B—gestational diabetes	0.000205	0.000842	CbGpPWpGaD
Arsenic trioxide—ABCB1—Integrated Pancreatic Cancer Pathway—AR—gestational diabetes	0.000203	0.000833	CbGpPWpGaD
Arsenic trioxide—JUN—SIDS Susceptibility Pathways—TNF—gestational diabetes	0.000202	0.000829	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—GLS2—gestational diabetes	0.000198	0.000813	CbGpPWpGaD
Arsenic trioxide—MAPK1—Regulation of toll-like receptor signaling pathway—TNF—gestational diabetes	0.000197	0.000806	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by NGF—FGF2—gestational diabetes	0.000196	0.000805	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—MTNR1B—gestational diabetes	0.000195	0.000801	CbGpPWpGaD
Arsenic trioxide—AKT1—Apoptosis—TNF—gestational diabetes	0.000195	0.000801	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—MBL2—gestational diabetes	0.000195	0.000798	CbGpPWpGaD
Arsenic trioxide—JUN—MAPK Signaling Pathway—TNF—gestational diabetes	0.000191	0.000781	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by NGF—FGF2—gestational diabetes	0.000191	0.000781	CbGpPWpGaD
Arsenic trioxide—IKBKB—Regulation of toll-like receptor signaling pathway—TNF—gestational diabetes	0.000188	0.000771	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—MBL2—gestational diabetes	0.000187	0.000766	CbGpPWpGaD
Arsenic trioxide—AKT1—MAPK Signaling Pathway—TNF—gestational diabetes	0.000183	0.000751	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by NGF—FGF2—gestational diabetes	0.000181	0.000743	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—MBL2—gestational diabetes	0.000181	0.000743	CbGpPWpGaD
Arsenic trioxide—MAPK3—MAPK Signaling Pathway—TNF—gestational diabetes	0.000178	0.000728	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	0.000177	0.000727	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—RBP4—gestational diabetes	0.000174	0.000713	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling by NGF—FGF2—gestational diabetes	0.000173	0.000711	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—MBL2—gestational diabetes	0.000172	0.000707	CbGpPWpGaD
Arsenic trioxide—JUN—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	0.000172	0.000705	CbGpPWpGaD
Arsenic trioxide—MAPK1—MAPK Signaling Pathway—TNF—gestational diabetes	0.000169	0.000693	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—RBP4—gestational diabetes	0.000169	0.000692	CbGpPWpGaD
Arsenic trioxide—AKT1—Developmental Biology—LEP—gestational diabetes	0.000167	0.000685	CbGpPWpGaD
Arsenic trioxide—AKT1—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	0.000165	0.000677	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—MBL2—gestational diabetes	0.000165	0.000677	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—LEPR—gestational diabetes	0.000165	0.000675	CbGpPWpGaD
Arsenic trioxide—MAPK3—Developmental Biology—LEP—gestational diabetes	0.000162	0.000664	CbGpPWpGaD
Arsenic trioxide—IKBKB—MAPK Signaling Pathway—TNF—gestational diabetes	0.000162	0.000663	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—RBP4—gestational diabetes	0.000161	0.000658	CbGpPWpGaD
Arsenic trioxide—MAPK3—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	0.00016	0.000657	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—LEPR—gestational diabetes	0.000158	0.000648	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—NAMPT—gestational diabetes	0.000156	0.00064	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—GCK—gestational diabetes	0.000155	0.000636	CbGpPWpGaD
Arsenic trioxide—MAPK1—Developmental Biology—LEP—gestational diabetes	0.000154	0.000632	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—LEPR—gestational diabetes	0.000153	0.000629	CbGpPWpGaD
Arsenic trioxide—MAPK1—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	0.000153	0.000625	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—NAMPT—gestational diabetes	0.000151	0.000621	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—GCK—gestational diabetes	0.00015	0.000617	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—LEPR—gestational diabetes	0.000146	0.000598	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—NAMPT—gestational diabetes	0.000144	0.00059	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—GCK—gestational diabetes	0.000143	0.000587	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Biological oxidations—CYP19A1—gestational diabetes	0.00014	0.000573	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—GGCT—gestational diabetes	0.00014	0.000573	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—LEPR—gestational diabetes	0.00014	0.000573	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metapathway biotransformation—CYP19A1—gestational diabetes	0.000138	0.000566	CbGpPWpGaD
Arsenic trioxide—ABCB1—Allograft Rejection—TNF—gestational diabetes	0.000137	0.000561	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—NAMPT—gestational diabetes	0.000131	0.000536	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—MTNR1B—gestational diabetes	0.00013	0.000534	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—GCK—gestational diabetes	0.00013	0.000532	CbGpPWpGaD
Arsenic trioxide—AKT1—Developmental Biology—FGF2—gestational diabetes	0.000127	0.00052	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—RBP4—gestational diabetes	0.000127	0.00052	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—MTNR1B—gestational diabetes	0.000125	0.000513	CbGpPWpGaD
Arsenic trioxide—MAPK3—Developmental Biology—FGF2—gestational diabetes	0.000123	0.000505	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—GLS2—gestational diabetes	0.000122	0.000501	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—RBP4—gestational diabetes	0.000122	0.0005	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—MTNR1B—gestational diabetes	0.000121	0.000497	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—LEP—gestational diabetes	0.000121	0.000496	CbGpPWpGaD
Arsenic trioxide—AKT1—Gene Expression—AR—gestational diabetes	0.000119	0.000487	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—RBP4—gestational diabetes	0.000118	0.000485	CbGpPWpGaD
Arsenic trioxide—MAPK1—Developmental Biology—FGF2—gestational diabetes	0.000117	0.00048	CbGpPWpGaD
Arsenic trioxide—JUN—Innate Immune System—FGF2—gestational diabetes	0.000117	0.000478	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—MTNR1B—gestational diabetes	0.000115	0.000473	CbGpPWpGaD
Arsenic trioxide—MAPK3—Gene Expression—AR—gestational diabetes	0.000115	0.000472	CbGpPWpGaD
Arsenic trioxide—ABCB1—Transmembrane transport of small molecules—GCK—gestational diabetes	0.000113	0.000465	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—RBP4—gestational diabetes	0.000112	0.000461	CbGpPWpGaD
Arsenic trioxide—AKT1—Innate Immune System—FGF2—gestational diabetes	0.000112	0.000459	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—GGCT—gestational diabetes	0.000112	0.000457	CbGpPWpGaD
Arsenic trioxide—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—gestational diabetes	0.000111	0.000455	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—MTNR1B—gestational diabetes	0.00011	0.000453	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	0.000109	0.000448	CbGpPWpGaD
Arsenic trioxide—MAPK3—Innate Immune System—FGF2—gestational diabetes	0.000109	0.000446	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—NAMPT—gestational diabetes	0.000109	0.000445	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—GCK—gestational diabetes	0.000108	0.000443	CbGpPWpGaD
Arsenic trioxide—AKT1—Adaptive Immune System—FGF2—gestational diabetes	0.000108	0.000441	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—RBP4—gestational diabetes	0.000108	0.000441	CbGpPWpGaD
Arsenic trioxide—MAPK1—Innate Immune System—FGF2—gestational diabetes	0.000103	0.000424	CbGpPWpGaD
Arsenic trioxide—IKBKB—Innate Immune System—FGF2—gestational diabetes	9.89e-05	0.000406	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—GLS2—gestational diabetes	9.75e-05	0.0004	CbGpPWpGaD
Arsenic trioxide—IKBKB—Adaptive Immune System—FGF2—gestational diabetes	9.5e-05	0.00039	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—CYP19A1—gestational diabetes	9.5e-05	0.000389	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—FGF2—gestational diabetes	9.19e-05	0.000377	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—CYP19A1—gestational diabetes	7.89e-05	0.000324	CbGpPWpGaD
Arsenic trioxide—AKT1—Developmental Biology—TNF—gestational diabetes	7.73e-05	0.000317	CbGpPWpGaD
Arsenic trioxide—MAPK3—Developmental Biology—TNF—gestational diabetes	7.49e-05	0.000307	CbGpPWpGaD
Arsenic trioxide—MAPK1—Developmental Biology—TNF—gestational diabetes	7.13e-05	0.000292	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—GGCT—gestational diabetes	6.87e-05	0.000282	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—FGF2—gestational diabetes	6.79e-05	0.000279	CbGpPWpGaD
Arsenic trioxide—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	6.76e-05	0.000277	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—NAMPT—gestational diabetes	6.69e-05	0.000274	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—GCK—gestational diabetes	6.65e-05	0.000273	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—FGF2—gestational diabetes	6.53e-05	0.000268	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—FGF2—gestational diabetes	6.33e-05	0.00026	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—FGF2—gestational diabetes	6.03e-05	0.000247	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—FGF2—gestational diabetes	6.02e-05	0.000247	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—GLS2—gestational diabetes	6.01e-05	0.000246	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—FGF2—gestational diabetes	5.84e-05	0.00024	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—LEP—gestational diabetes	5.78e-05	0.000237	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—FGF2—gestational diabetes	5.76e-05	0.000236	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—FGF2—gestational diabetes	5.56e-05	0.000228	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—LEP—gestational diabetes	5.55e-05	0.000228	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—LEP—gestational diabetes	5.39e-05	0.000221	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—NAMPT—gestational diabetes	5.34e-05	0.000219	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—GCK—gestational diabetes	5.31e-05	0.000218	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—LEP—gestational diabetes	5.13e-05	0.00021	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—LEP—gestational diabetes	4.9e-05	0.000201	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—CYP19A1—gestational diabetes	4.86e-05	0.000199	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—FGF2—gestational diabetes	4.39e-05	0.00018	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—FGF2—gestational diabetes	4.22e-05	0.000173	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—FGF2—gestational diabetes	4.09e-05	0.000168	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—FGF2—gestational diabetes	3.89e-05	0.00016	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—CYP19A1—gestational diabetes	3.88e-05	0.000159	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—FGF2—gestational diabetes	3.73e-05	0.000153	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—NAMPT—gestational diabetes	3.29e-05	0.000135	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—GCK—gestational diabetes	3.27e-05	0.000134	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—CYP19A1—gestational diabetes	2.39e-05	9.81e-05	CbGpPWpGaD
